Does Nitrofurantoin Cover Enterococcus Faecalis?
Yes, nitrofurantoin is highly effective against Enterococcus faecalis and is recommended as a first-line treatment option for urinary tract infections caused by this organism.
Guideline-Based Recommendations
Both major international guidelines explicitly support nitrofurantoin for uncomplicated cystitis, which commonly involves E. faecalis. The 2024 JAMA guidelines identify nitrofurantoin as "a reasonable drug of choice" for uncomplicated cystitis based on robust efficacy evidence 1. The 2024 European Association of Urology guidelines list nitrofurantoin as first-line treatment for uncomplicated cystitis in women, with recommended dosing of 50-100 mg four times daily or 100 mg twice daily for 5 days 2.
Microbiological Evidence
The susceptibility data strongly supports nitrofurantoin's activity against E. faecalis:
- Vancomycin-susceptible E. faecalis: Multiple studies demonstrate >90% susceptibility to nitrofurantoin 3, 4
- Vancomycin-resistant E. faecalis (VRE): Maintains >90% susceptibility even in multidrug-resistant strains 3, with one study showing 88% susceptibility among resistant enterococci 4
- Historical consistency: A 2001 study found no isolates resistant to nitrofurantoin among 300 enterococcal strains tested, including VRE 5
The most recent 2024 study examining vancomycin-resistant isolates in British Columbia found that vancomycin-resistant E. faecalis remained >90% susceptible to nitrofurantoin, making it a reliable oral option alongside ampicillin and linezolid 3.
Important Caveats
E. faecium vs. E. faecalis
Critical distinction: While nitrofurantoin works well for E. faecalis, it has poor activity against E. faecium. The 2024 study showed <15% susceptibility for vancomycin-resistant E. faecium 3. For E. faecium urinary infections, linezolid is the only reliable oral option.
Geographic Variation
A 2025 study from western Gujarat showed only 69.69% sensitivity to nitrofurantoin for E. faecalis 6, demonstrating that local resistance patterns matter. Always consider your institution's antibiogram when available.
Urinary Tract Infections Only
Nitrofurantoin achieves high urinary concentrations but minimal serum and tissue levels 7. Do not use nitrofurantoin for:
- Pyelonephritis
- Bacteremia
- Prostatitis
- Any systemic enterococcal infection
The drug is FDA-approved and appropriate only for lower urinary tract infections (cystitis) 8.
Renal Function
The FDA label warns against use in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased risk of peripheral neuropathy 8.
Clinical Bottom Line
For uncomplicated cystitis caused by E. faecalis, nitrofurantoin is an excellent first-line choice with high efficacy, low resistance rates, and minimal collateral damage to gut microbiota 7. Use 100 mg twice daily for 5 days 1, 2. However, confirm the species is E. faecalis (not E. faecium), ensure adequate renal function, and limit use to lower urinary tract infections only.